Poison for Profit: Malawi’s Expired Insulin Scandal

by | Apr 17, 2026 | pijmalawi

How a pharmaceutical company traded defective medication, leaving vulnerable patients exposed due to regulatory loopholes. BY GOLDEN MATONGA AND TUMPALE NG’AMBIBehind the gleaming mahogany desk in the managing director’s office, a wall of polished trophies projects order and success. But an investig…

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by